Document is current
Any future updates will be listed below
-
Authors
Bhave, Aditya https://orcid.org/0009-0001-1271-0531
Hyma Kunhiraman, Harikrishnan https://orcid.org/0000-0002-6395-7956
Nahle, Tarek https://orcid.org/0009-0004-4584-3308
Reddy, Ritu
Makram, Omar https://orcid.org/0000-0001-8361-9068
Nain, Priyanshu https://orcid.org/0000-0003-0008-0779
Shah, Viraj
Swami, Umang https://orcid.org/0000-0003-3518-0411
Patel, Sagar A. https://orcid.org/0000-0001-5174-2096
Esdaille, Ashanda
Terris, Martha https://orcid.org/0000-0002-3843-7270
Guha, Avirup https://orcid.org/0000-0003-0253-1174
-
Funding
Funding for this research was provided by:
American Heart Association (847740, 863620)
U.S. Department of Defense (HT94252310158)
- License Information
-
More Information
Article History
Received: 8 April 2025
Revised: 25 June 2025
Accepted: 3 July 2025
First Online: 14 July 2025
Competing interests
: AG has consulted for Myovant, Novartis, and Pfizer, but has no conflict of interest associated with this work. None of the other authors have any conflicts of interest related to this work to disclose.
